Saint Bella (02508.HK) Peaked Upon Listing: Why the “Hermès of Postnatal Care” Could Not Rescue Its Share Price

ZC Asia has learnt that Saint Bella (02508.HK), founded in 2017, originated when overseas-educated second-generation entrepreneurs Xiang Hua and Lin Wanyi identified a gap in China's high-end postnatal care centre market, establishing Beikang International in Hangzhou. From its inception in 2017 until its 2025 IPO, the company completed ten rounds of financing, attracting investments from prominent institutions including Gaorong Capital, Tencent, and Sun Hung Kai.

By 2024 postnatal care centre revenue, this enterprise stands as Asia and China's largest postnatal care and recovery group, underpinned by its network of 96 premium postnatal care centres across 30 cities.

On 26 June 2025, Saint Bella listed on the Main Board of the Hong Kong Stock Exchange, globally offering 109.733 million shares priced at HK$6.58 each, raising net proceeds of approximately HK$630 million. On its debut trading day, Saint Bella's share price surged to HK$11 per share, representing a 67.17% increase over the issue price, before closing at HK$8.80 per share, narrowing the gain to 33.74%.

However, this moment of glory proved fleeting. On the following trading day, Saint Bella's share price plummeted by 25.57%, closing below its issue price.

The company's share price subsequently experienced a volatile decline, spending most of the period below its issue price. Since 21st October, the share price has not regained the issue price level.

As of 5th February 2026, the latest share price stood at HK$4.85, with a trading volume of 1.906 million shares and a turnover rate of merely 0.31%, resulting in a total market capitalisation of approximately HK$3.018 billion.

The prolonged share price slump stems from deep-seated capital market scepticism regarding Shengbella's sustainable profitability – a doubt not entirely unfounded.

Dubbed the ‘most expensive postnatal care centre’ and the ‘Hermès of the postnatal care industry,’ Saint Bella pursues an uncompromisingly premium strategy.

Taking its three Shenzhen outlets as an example, the entry-level 28-day postnatal care package starts at RMB 168,800, while the 56-day package commands a maximum fee of RMB 1,048,000. Services include 24-hour one-to-one nursing care by specialist nurses, ward rounds by consultant-level physicians, and Michelin-standard postnatal meals.

Celebrity clients include Qi Wei, Gina, and Tang Yixin. In October 2025, when Aaron Kwok and Fang Yuan welcomed their third daughter, market rumours suggested Fang stayed at Saint Bella's K11 branch in Tsim Sha Tsui, Hong Kong, opting for the 56-day ‘Queen Package’ priced between HK$1.79 million and HK$2 million.

However, high fees do not necessarily translate to high profits. Data reveals that from 2021 to 2024, Saint Bella's revenues stood at RMB 259 million, RMB 472 million, RMB 560 million, and RMB 799 million respectively.

Yet net profits recorded losses of RMB 119 million, RMB 407 million, RMB 239 million, and RMB 547 million respectively, accumulating total losses of RMB 1.312 billion over four years – a strategy of ‘sacrificing profits for publicity’.

In the first half of 2025, Shengbella finally achieved an accounting profit, with revenue reaching RMB 450 million, a year-on-year increase of 25.64%, and net profit standing at RMB 327 million.

The company attributed this to its ‘Partnership Store Programme’, which saw the number of entrusted maternity centres increase by 34 within six months, bringing the total to 53. Revenue from entrusted management stores surged by 159.6% year-on-year.

However, within this ¥327 million net profit, ¥318 million represented gains from changes in the fair value of financial instruments issued to investors. Excluding this income, the company's actual profit stood at merely ¥8.848 million.

This figure reveals a stark reality: Shengbella's core business profitability remains highly fragile, with profit growth relying more on fluctuations in financial instrument valuations than on actual service-based earnings.

Faced with intense domestic competition and profitability challenges, Shengbella adopted an overseas expansion strategy.

In July 2025, Shengbella established a presence in premium venues such as the Waldorf Astoria Resort Hotel in California and the Baccara Hotel in New York, seeking to replicate its domestic success model.

By August 2025, Shengbella's global store network had expanded to 113 locations across multiple countries and regions, aiming to diversify operational risks through international expansion.

The company also leveraged AI advancements to upgrade its intelligent SaaS+AI infrastructure while advancing strategic initiatives in newborn care, elderly nursing, and health foods to build a diversified service ecosystem.

The “Hermès” aura of premium postnatal care centres may attract celebrity clients and capital attention, but to sustain investor confidence, Shengbella must demonstrate not only market share but also the capacity to generate consistent cash flow.

Disclaimer: The content herein is for reference only and does not constitute any form of investment advice. Should any information contained herein prove inaccurate, incomplete, or potentially misleading, please refer to the company's official announcements. Market risks exist; investment requires caution.